Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis
World Journal of Gastroenterology2016Vol. 22(12), pp. 3451–3459
Citations Over TimeTop 14% of 2016 papers
Abstract
The IBS-D and UC groups showed similar clinical symptom scores, visceral sensitivity, and levels of serotonin signaling pathway indicators in the plasma and colonic mucosa. However, the pain threshold and 5-HT7R expression in the colonic mucosa were significantly different between these groups. The results reveal that (1) IBS-D and UC are related to visceral sensitivity pathogenesis and the clinical manifestations of these conditions and (2) the observed differences in visceral hypersensitivity are possibly due to differences in levels of the 5-HT7 receptor, a component of the 5-HT signaling pathway.
Related Papers
- → Abdominal Pain Impacts Quality of Life in Women with Irritable Bowel Syndrome(2006)105 cited
- Smoking in inflammatory bowel disease and the irritable bowel syndrome.(1986)
- → A Case Report of Irritable Bowel Syndrome in a Patient that Improved with Banhasasim-tang and Yukgunja-tang-gami(2020)4 cited
- → Human Colonic Motility: A Comparative Study of Normal Subjects, Patients with Ulcerative Colitis, and Patients with the Irritable Colon Syndrome(1961)65 cited
- The Effect of Pinaverium Bromid on the Patients with Diarrhea Predominant Irritable Bowel Syndrome(2013)